During the last session, Pulmonx Corp (NASDAQ:LUNG)’s traded shares were 0.36 million, with the beta value of the company hitting 0.74. At the end of the trading day, the stock’s price was $4.52, reflecting an intraday loss of -5.64% or -$0.27. The 52-week high for the LUNG share is $10.01, that puts it down -121.46 from that peak though still a striking -4.42% loss since the share price plummeted to a 52-week low of $4.72. The company’s market capitalization is $181.92M, and the average intraday trading volume over the past 10 days was 0.43 million shares, and the average trade volume was 349.16K shares over the past three months.
Pulmonx Corp (LUNG) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.57. LUNG has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
Pulmonx Corp (NASDAQ:LUNG) trade information
Pulmonx Corp (LUNG) registered a -5.64% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -5.64% in intraday trading to $4.52, hitting a weekly high. The stock’s 5-day price performance is -13.24%, and it has moved by -41.83% in 30 days. Based on these gigs, the overall price performance for the year is -39.08%. The short interest in Pulmonx Corp (NASDAQ:LUNG) is 1.23 million shares and it means that shorts have 4.57 day(s) to cover.
The consensus price target of analysts on Wall Street is $10, which implies an increase of 54.8% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $10 and $10 respectively. As a result, LUNG is trading at a discount of -121.24% off the target high and -121.24% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -19.80%. While earnings are projected to return -7.39% in 2025, the next five years will return 10.09% per annum.
LUNG Dividends
Pulmonx Corp is due to release its next quarterly earnings on 2025-Feb-18. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Pulmonx Corp (NASDAQ:LUNG)’s Major holders
Pulmonx Corp insiders own 5.77% of total outstanding shares while institutional holders control 92.31%, with the float percentage being 97.97%. PRIMECAP MANAGEMENT CO/CA/ is the largest shareholder of the company, while 168.0 institutions own stock in it. As of 2024-06-30, the company held over 5.71 million shares (or 14.6622% of all shares), a total value of $36.2 million in shares.
The next largest institutional holding, with 5.28 million shares, is of FMR LLC’s that is approximately 13.5609% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $33.48 million.
Also, the Mutual Funds coming in first place with the largest holdings of Pulmonx Corp (LUNG) shares are PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund and Fidelity Securities Fund-Fidelity Small Cap Growth Fund . Data provided on Jan 31, 2025 indicates that PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund owns about 3.81 shares. This amounts to just over 9.47 percent of the company’s overall shares, with a $17.22 million market value. The same data shows that the other fund manager holds slightly less at 1.49, or about 3.71% of the stock, which is worth about $6.75 million.
